Floatz logo

Therapeutic Asset Ratings

748 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Triadeno Vaccine
Epithelial Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Tumor Lysate, Particle Only Vaccine
Metastatic Neoplasm
Elios Therapeutics, LLCP2CCC (53)
Tumor Lysate, Particle Only Vaccine
Neoplasm
Elios Therapeutics, LLCP2CCC (53)
uv1
Neoplasm
Vestre Viken Hospital TrustP2CCC (53)
Wokvac Vaccine
Breast Cancer
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Wokvac Vaccine
Male Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Wokvac Vaccine
Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Wokvac Vaccine
Residual Disease
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Ino-9012
Hepatocellular Carcinoma
Geneos TherapeuticsP1/2CCC (53)
ADAGLOXAD SIMOLENIN
Triple-Negative Breast Carcinoma
OBI Pharma, IncP3CCC (52)
Moderna Bivalent Mrna Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Monash UniversityP3CCC (52)
pcv21
Sickle Cell Disease
SanofiP3CCC (52)
Pfizer Bivalent Covid-19 Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Monash UniversityP3CCC (52)
Prevnar 20
Sickle Cell Disease
SanofiP3CCC (52)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2CCC (52)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Hodgkins Lymphoma
City of Hope Medical CenterP2CCC (52)
Neoantigen Dendritic Cell Vaccine
Hepatocellular Carcinoma
National Cancer Centre, SingaporeP2CCC (52)
Pneumococcal Polyvalent Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Seema BhatP2CCC (52)
Allostim®
Hepatocellular Carcinoma
Mirror Biologics, Inc.P2/3CCC (52)
ad5 cea vaccine
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Adenovirus 5 Cea/Muc1/Brachyury Vaccine Tri-Ad5
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre
Colorectal Adenocarcinoma
Thomas Jefferson UniversityP2CCC (51)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre
Gastric Adenocarcinoma
Thomas Jefferson UniversityP2CCC (51)
Dpx-Survivac
Cancer
University Health Network, TorontoP2CCC (51)
Dpx-Survivac
Urinary Bladder Carcinoma
ImmunoVaccine Technologies, Inc. (IMV Inc.)P2CCC (51)
Showing 301 to 325 of 748 assets
PreviousPage 13 of 30Next